Spencer B King
Affiliation: Piedmont Hospital
- Do elderly patients with non-ST-segment elevation acute coronary syndromes benefit from early invasive treatment?Spencer B King
Emory University School of Medicine
Nat Clin Pract Cardiovasc Med 3:188-9. 2006
- Applying drug-eluting stents in clinical practiceSpencer B King
Fuqua Heart Center at Piedmont Hospital, Atlanta, Georgia 30309, USA
Am J Cardiol 100:25K-31K. 2007..Safety of the procedure must continue to be the first consideration, and technique must not be compromised to accommodate new technology...
- Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stentLakshmana K Pendyala
Saint Joseph s Translational Research Institute, Atlanta, Georgia 30313, USA
JACC Cardiovasc Interv 5:436-44. 2012....
- High-density lipoprotein subclasses and their relationship to cardiovascular diseaseH Robert Superko
Mercer University School of Pharmacy Sciences, Atlanta, GA, USA
J Clin Lipidol 6:496-523. 2012..To assess the clinical utility of measuring high-density lipoprotein (HDL) subfractions to assess coronary heart disease (CHD) risk...
- Vasomotor function after paclitaxel-coated balloon post-dilation in porcine coronary stent modelTakamitsu Nakamura
Saint Joseph s Translational Research Institute Saint Joseph s Hospital of Atlanta, Atlanta, Georgia 30313, USA
JACC Cardiovasc Interv 4:247-55. 2011..The purpose of this study was to evaluate endothelial function after post-dilation of bare-metal stents with paclitaxel-coated balloons (PCB) or non-drug-coated balloons (non-DCB) in a porcine model...
- Ambulatory discharge after transradial coronary intervention: Preliminary US single-center experience (Same-day TransRadial Intervention and Discharge Evaluation, the STRIDE Study)Refat Jabara
Saint Joseph s Cardiovascular Research Institute, Saint Joseph s Hospital of Atlanta, Atlanta, GA 30342, USA
Am Heart J 156:1141-6. 2008..Although the safety and cost-effectiveness of same-day discharge after uncomplicated transradial percutaneous coronary intervention (TR-PCI) is well established in Europe and Asia, such data are not available for US patients...
- Comparison of the clinical characteristics of apical and non-apical variants of "broken heart" (takotsubo) syndrome in the United StatesRefat Jabara
Saint Joseph s Cardiovascular Research Institute, Saint Joseph s Hospital of Atlanta, 5673 Peachtree Dunwoody Road, Suite 675, Atlanta, GA 30342, USA
J Invasive Cardiol 21:216-22. 2009..The present study was designed to delineate and compare the clinical characteristics of patients with apical and non-apical takotsubo syndrome in a high-volume U.S. hospital...
- Late angiographic stent thrombosis: the LAST straw for drug-eluting stents?Jack P Chen
Department of Cardiology, Saint Joseph s Hospital of Atlanta, Atlanta, Georgia, USA
Angiology 59:667-75. 2008..Moreover, when deployed for "on-label" indications, they provide significant restenosis advantage, with a slight late thrombotic risk but without overall increase in death or infarction...
- Firefighters, heart disease, and aspects of insulin resistance: the FEMA Firefighter Heart Disease Prevention studyH Robert Superko
Saint Josephs Research Institute, Mercer University School of Pharmaceutical Sciences, Atlanta, Georgia, USA
J Occup Environ Med 53:758-64. 2011..To determine the association of cardiovascular risk markers with noninvasive imaging of atherosclerosis in firefighters...
- Clinical and angiographic features of small vessel stenting in the drug-eluting stent eraRefat Jabara
Saint Joseph s Cardiovascular Research Institute, Saint Joseph s Hospital of Atlanta, Atlanta, Georgia 30342, USA
Clin Cardiol 32:E40-5. 2009....
- Revascularization for coronary artery disease: stents versus bypass surgerySpencer B King
Saint Joseph s Heart and Vascular Institute, Atlanta, Georgia 30342, USA
Annu Rev Med 61:199-213. 2010..It is in this patient population where the debate over revascularization with stents versus surgery continues...
- Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stressLakshmana K Pendyala
Saint Joseph s Translational Research Institute Saint Joseph s Hospital of Atlanta, Atlanta, Georgia 30342, USA
JACC Cardiovasc Interv 2:253-62. 2009..production after overlapping paclitaxel-eluting stent (PES) implantation in a porcine model...
- Angioplasty is better than medical therapy for alleviating chronic angina pectorisSpencer B King
Fuqua Heart Center, Piedmont Hospital, 95 Collier Road NW, Ste 2075, Atlanta, GA 30309, USA
Arch Intern Med 165:2589-92, discussion 2592-3. 2005
- From balloon angioplasty to drug-eluting stents: revolution or evolution?Spencer B King
Cardiology of Georgia, 95 Collier Road NW, Suite 2075, Atlanta, GA 30309 1749, USA
Am Heart Hosp J 2:73-9. 2004..As more data are accumulated, prudent selective use of drug-eluting stenting seems most appropriate...
- Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary interventionRefat Jabara
Saint Joseph s Cardiovascular Research Institute Saint Joseph s Hospital of Atlanta, Atlanta, Georgia, USA
Am J Cardiol 103:1657-62. 2009..The wide variation in CIN and its lack of association with adverse outcomes underscore the need for a standardized, clinically relevant definition...
- Is surgery preferred for the diabetic with multivessel disease? Surgery is preferred for the diabetic with multivessel diseaseSpencer B King
The Fuqua Heart Center, Atlanta, GA 30309, USA
Circulation 112:1500-7; discussion 1514-5. 2005
- Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemiaH Robert Superko
Saint Joseph s Translational Research Institute, Atlanta, GA, USA
Am J Cardiol 103:387-92. 2009..In conclusion, this investigation revealed that a combination of a fibric acid derivative and nicotinic acid offers greater improvement in detailed lipoprotein subclass distribution and apolipoprotein ratios than monotherapy...
- Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist eraZiyad Ghazzal
Andreas Gruentzig Cardiovascular Center of Emory University School of Medicine, Division of Cardiology, Atlanta, GA, USA
Am Heart J 145:1006-12. 2003..We evaluated the significance of creatine phosphokinase level (CPK) elevations in a large cohort of patients who had undergone an elective PCI before the IIb/IIIa receptor antagonist era...
- Commentary for "Comparison of drug eluting stents with bare metal stents in unselected patients with acute myocardial infarction"Spencer B King
Catheter Cardiovasc Interv 71:E1-2. 2008
- Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BV S Srinivas
Department of Medicine, Division of Cardiovascular Medicine, Albert Einstein College of Medicine Montefiore Medical Center, Bronx, NY, USA
Circulation 106:1627-33. 2002..Patients having balloon angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI) and those within the Dynamic Registry meeting BARI eligibility criteria were studied...
- Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) unstable angina/non-ST elevation myocardial infarction critical pathway toolkitChristopher P Cannon
TIMI Study Group, Brigham and Women s Hospital, Boston, MA 02115, USA
Crit Pathw Cardiol 7:43-81. 2008..These materials are being made available online to help physicians, nurses, and hospitals implement the new guidelines and thus improve the quality of care and outcomes for patients with ACS...
- Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)Warren K Laskey
University of Maryland School of Medicine, Baltimore, Maryland, USA
Am J Cardiol 90:1062-7. 2002..73, 95% CI 0.61 to 0.88; adjusted RR in patients with diabetes 1.20, 95% CI 0.88 to 1.65). Beta blockers at the time of hospital discharge were significantly associated with reduced mortality rates at 1 year in both groups...
- A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stentsEdward L Hannan
School of Public Health, University at Albany, State University of New York, Albany, NY 12144 3456, USA
Am Heart J 154:545-53. 2007..There are only 2 approved devices: sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES). Only a few population-based studies have compared their patient outcomes...
- Restenosis: the mouse that roaredSpencer B King
Circulation 108:248-9. 2003
- ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Spencer B King
Circulation 116:98-124. 2007
- Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS-II): prologue to COURAGESpencer B King
Circulation 115:1064-6. 2007
- Volume-outcome relationships for percutaneous coronary interventions in the stent eraEdward L Hannan
State University of New York, Albany, NY, USA
Circulation 112:1171-9. 2005..Most studies that are the basis of recommended volume thresholds for percutaneous coronary interventions (PCIs) predate the routine use of stent placement...
- Bare-metal stent outcomes in an unselected patient populationA Yock
Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, California 94305 6019, USA
Clin Cardiol 29:352-6. 2006..Randomized trials have shown that drug-eluting stents (DES) substantially reduce in-stent restenosis compared with bare-metal stents (BMS)...
- ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Spencer B King
J Am Coll Cardiol 50:82-108. 2007
- A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery diseaseV S Srinivas
Circulation 107:e88. 2003
- Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stentsEdward L Hannan
School of Public Health, State University of New York, University at Albany, One University Place, Rensselaer, NY 12144 3456, USA
Circulation 117:2071-8. 2008..The purpose of the present study was to compare outcomes for patients who underwent stenting in the eras before and after the introduction of DES...
- Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery TrialXue Qiao Zhao
Department of Medicine, Cardiology Division, University of Washington School of Medicine, Seattle, WA 98103, USA
Med Sci Monit 9:CR48-54. 2003..The natural history of atherosclerosis progression following revascularization procedures (PTCA or CABG) limits the long-term benefits of these procedures and requires continuation of risk management...
- Why have stents replaced balloons? Underwhelming evidenceSpencer B King
Ann Intern Med 138:842-3. 2003
- Dilate or defer? View of a skepticSpencer B King
J Am Coll Cardiol 42:1171-2. 2003
- Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trialDavid R Holmes
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
Circulation 106:1243-50. 2002..No oral agent has shown a beneficial effect on restenosis or on associated major adverse cardiovascular events. In limited trials, the oral agent tranilast has been shown to decrease the frequency of angiographic restenosis after PCI...
- A risk score to predict in-hospital mortality for percutaneous coronary interventionsChuntao Wu
University at Albany, State University of New York, Albany, New York, USA
J Am Coll Cardiol 47:654-60. 2006..Our purpose was to develop a risk score to predict in-hospital mortality for percutaneous coronary intervention (PCI) using a statewide population-based PCI registry...
- Enoxaparin versus unfractionated heparin in elective percutaneous coronary interventionGilles Montalescot
Institut de Cardiologie, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
N Engl J Med 355:1006-17. 2006..Several small studies have suggested that intravenous enoxaparin may be a safe and effective alternative. Our primary aim was to assess the safety of enoxaparin as compared with that of unfractionated heparin in elective PCI...
- Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent eraEdward L Hannan
State University of New York, University at Albany, Rensselaer, NY 12144 3456, USA
Circulation 113:2406-12. 2006....
- Differences in utilization of drug-eluting stents by race and payerEdward L Hannan
University at Albany, State University of New York, Albany, NY, USA
Am J Cardiol 100:1192-8. 2007..93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely...
- The editor's roundtable: chronic stable angina pectorisVincent E Friedewald
Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA
Am J Cardiol 100:1635-43. 2007
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence anSpencer B King
Circulation 117:261-95. 2008
- 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelinesSpencer B King
J Am Coll Cardiol 51:172-209. 2008
- SCAI statement on drug-eluting stents: practice and health care delivery implicationsJohn McB Hodgson
Heart and Vascular Center, MetroHealth Medical Center, Cleveland, Ohio 44109, USA
Catheter Cardiovasc Interv 58:397-9. 2003